Laguna Acquires the Exclusive CannaCeuticals CBD Skin Care Licenses and White Label Rights for Japan, Germany, Thailand and South Korea

  KELOWNA BC - 10/31/2016 (PRESS RELEASE JET)

Laguna Blends Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) (the “Company” or “Laguna”), today announces the exclusive Cannaceutical  CBD skin care license has been expanded into Japan, Germany, Thailand and South Korea.

ISO International LLC (“ISO”), (the supplier for Cannaceuticals) has granted to Laguna the exclusive, transferable, perpetual, irrevocable, royalty-free right and license to distribute the products in the licensed territories, either under the product trademarks or on a white label basis. In addition, Laguna may sub-license these rights and licenses to any third party without the consent of the supplier.

The expansion of the additional licensed territories in Asia and Europe fast tracks Laguna to be a worldwide player in the distribution of Cannabidiol (“CBD”) skin care products. The global skin care industry is currently estimated at $121 billion US and the market demand for CBD products is growing at an expediential rate.

Laguna is positioning itself in the multibillion dollar skin care market. Laguna’s market strategy is online sales, joint ventures and through licensing opportunities.

Laguna previously announced that it had received an exclusive license for the CannaCeutical product line in the USA and Canada, see press release dated August 09, 2016. Laguna launched sales of the Cannaceutical products in the USA on September 13th of 2016.

Stuart Gray, CEO of Laguna Blends said, “By acquiring the additional exclusive licenses in Japan, Germany, Thailand and South Korea we can capitalize on the global demand for high quality skin care products.” Stuart Gray went on to say, “We feel there is nothing like the Cannaceutical product line anywhere in the world today and in a recent clinical study evaluating the efficacy of Canna’s CBD facial serum, test subjects using the product noted a 100% overall improvement to the appearance of skin in just two weeks.”

Sherrie Berry, the formulator of Cannaceuticals by Laguna Blends explains in a 19-minute interview why the products work so well and why they’re unique in the skin care industry. https://www.youtube.com/watch?v=EXlAzDAm6FM 

What is Cannabidiol
Cannabidiol (“CBD”) is a non-psychoactive cannabinoid found in abundance in the hemp plant. Hemp genetics are naturally rich in CBD as well as other non-psychoactive cannabinoids and phytochemicals. CBD, and all the other cannabinoids in the cannabis plant, were patented by the United States Government in 2003 as neuroprotectants and antioxidants.

None of the statements contained in this news release are health claims and the FDA has not evaluated these claims. Laguna's products and proposed products are not intended to diagnose, treat, cure or prevent any disease.

CannaCeuticals, CBD Skin Care Products

(“CannaCeuticals”), Swiss heritage is at the core of Canna’s revolutionary skincare products. It’s pure, cosmeceutical-grade CBD extract hails from the crisp, clean air of Switzerland, but Canna’s heritage goes much further than that. Swiss culture is known for its precision and perfectionism, and CannaCeuticals radiates that same standard in every formula it produces.  Canna’s team of formulators are made up of chemists and product developers that analyze every detail, sourcing ingredients from all ends of the earth to create the most balanced, highly efficacious, anti-aging CBD skincare products in the world.

CannaCeuticals CBD7 anti-aging skincare products incorporate CBD, a superior antioxidant and a potential anti-inflammatory agent, both of which are significant in anti-aging. Canna’s Swiss heritage influences a sense of unity in its products, and it combines CBD with other essential anti-aging ingredients to create formulas that pack a powerful punch.

Clinical trials were conducted by BioScreen Testing Services, Inc., a third-party FDA approved lab located in the USA.  The test subjects that used the Cannaceutical facial serum noticed a 100% overall improvement of the skin appearance within a two-week period.

Laguna has signed a distribution agreement with ISO International, LLC, a transaction under which Laguna has acquired the exclusive right to market, promote and distribute seven CBD skin care products of CannaCeuticals of California, USA (“Canna”)
https://cbdskincream.com/

What is Cannabidiol
Cannabidiol is a non-psychoactive cannabinoid found in abundance in the hemp plant. Hemp genetics are naturally rich in cannabidiol as well as other non-psychoactive cannabinoids and phytochemicals. Cannabidiol, and all the other cannabinoids in the cannabis plant, were patented by the United States Government in 2003 as neuroprotectants and antioxidants.

About Laguna Blends Inc.
Laguna is a marketing company that generates retail sales through a proprietary, online, social media platform, driven by affiliates. Laguna currently markets products in the USA and Canada. In addition, Laguna is seeking joint ventures, acquisitions and wholesale distribution opportunities in the hemp and CBD industry. Laguna is planning an aggressive international expansion into Asia and Europe in 2017. Laguna offers both hemp and CBD related products.

ON BEHALF OF THE BOARD
“Stuart Gray”
Chief Executive Officer

CORPORATE COMMUNICATIONS:
Howe & Bay
Suite 600 - 535 Howe St.
Vancouver BC
V6C 2Z4
1.604.449.5302

COMPANY:
Laguna Blends
www.lagunablends.com
https://cbdskincream.com/

Join Us On Face Book: https://www.facebook.com/LagunaBlends/
Twitter: @LagunaBlends

Join to receive Laguna’s news feed: http://lagunablendsinc.com/newsletter/

Forward-Looking Information:
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release. None of the statements contained in this news release are health claims and the FDA has not evaluated these claims.  Laguna’s products and proposed products are not intended to diagnose, treat, cure or prevent any disease.